Merck known as MSD outside the United States and Canada, announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has unanimously recommended…
Merck Announces Positive EU CHMP Recommendation for WINREVAIR™ (Sotatercept) in Treating Pulmonary Arterial Hypertension (PAH) Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that…
Allergan Aesthetics, a division of AbbVie (NYSE: ABBV), has launched Allē Payment Plans, powered by Cherry, to offer consumers the ability to pay for aesthetic treatments and products, including BOTOX®…
AbbVie announced today the acquisition of Celsius Therapeutics, Inc. (“Celsius”), a privately held biotechnology company pioneering new therapies for inflammatory diseases. Celsius’ lead investigational asset, CEL383, is a potential first-in-class…
Linear Health Sciences has announced significant advancements for its Orchid SRV™, a breakthrough safety valve designed to enhance the use of medical tubing in hospital settings. Since its latest FDA…
Augustine Therapeutics, a pioneering biotech firm dedicated to advancing treatments for neurodegenerative and cardiometabolic diseases, has successfully closed its Series A funding round with EUR 17 million (USD 18.5 million).…
Cayuga Biotech introduced groundbreaking preclinical findings today on its innovative polyphosphate (polyP)-based therapy aimed at combating life-threatening hemorrhage. The study revealed that the polyP-SNP (silica nanoparticle) complex accelerates thrombin production…
TVM Capital Healthcare Announces $35 Million Investment in Boston Oncology Arabia TVM Capital Healthcare, an international healthcare expansion and growth capital firm, has announced a $35 million investment in Boston…
ImmunoPrecise Antibodies Ltd. (IPA), an AI-driven biotherapeutic research and technology company, announced a strategic collaboration between its subsidiary, BioStrand, and PGxAI. This partnership aims to leverage BioStrand’s patented LENSai Foundation…
PQE Group, a prominent consultancy in the Life Science sector, has announced the launch of its new Regulated Artificial Intelligence & Data Analytics division. This development follows the integration of…
As the world’s largest pure-play consumer health company by revenue, Kenvue has released its first-ever Healthy Lives Mission Report, highlighting the company’s efforts to enhance the well-being of both people…
argenx Receives FDA Approval for VYVGART® Hytrulo with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy Today, Halozyme announced that the U.S. Food and Drug Administration (FDA) has approved argenx’s VYVGART® Hytrulo…